Siemens AG (SIE):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Siemens AG (SIE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10170
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution; oil and gas production and transportation; medical imaging and laboratory diagnostics; audiology solutions; industrial technologies and automation systems; infrastructure and building technologies; and mobility and logistics solutions. Siemens also offers drive and software solutions, besides business-to-business financial solutions. Its customers include public utilities, independent power producers, oil and gas companies, hospitals and diagnostics centers, transportation companies, network operators, infrastructure developers, and industrial companies. The company has operations across Europe, Commonwealth of Independent States, Africa, the Middle East, Americas, and Asia Pacific. Siemens is headquartered in Munich, Germany.

Siemens AG (SIE) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Siemens AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Siemens AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Siemens AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Siemens AG, Medical Devices Deals, 2012 to YTD 2018 8
Siemens AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Siemens AG, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
ICBio to Raise up to USD2 Million in Private Equity 10
Partnerships 11
Siemens Healthcare Enters into Co-Development Agreement with Biogen 11
Equity Offering 12
Siemens Healthcare Raises USD5.71 Billion in IPO 12
Asset Transactions 14
Beckman Coulter To Acquire Clinical Microbiology Business Of Siemens 14
Siemens AG – Key Competitors 15
Siemens AG – Key Employees 16
Siemens AG – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Affiliate 25
Joint Venture 25
Recent Developments 26
Other Significant Developments 26
Aug 22, 2018: Siemens helps bring comfort and efficiency to Louisiana Hospital 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Siemens AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Siemens AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Siemens AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Siemens AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Siemens AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Siemens AG, Medical Devices Deals, 2012 to YTD 2018 8
Siemens AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ICBio to Raise up to USD2 Million in Private Equity 10
Siemens Healthcare Enters into Co-Development Agreement with Biogen 11
Siemens Healthcare Raises USD5.71 Billion in IPO 12
Beckman Coulter To Acquire Clinical Microbiology Business Of Siemens 14
Siemens AG, Key Competitors 15
Siemens AG, Key Employees 16
Siemens AG, Subsidiaries 18
Siemens AG, Affiliate 25
Siemens AG, Joint Venture 25

List of Figures
Siemens AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Siemens AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Siemens AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Siemens AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Siemens AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Siemens AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Siemens AG, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Siemens AG (SIE):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alfa Group Consortium:企業の戦略的SWOT分析
    Alfa Group Consortium - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Kratos Defense & Security Solutions, Inc.:戦略・SWOT・企業財務分析
    Kratos Defense & Security Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kratos Defense & Security Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Buckeye Partners, L.P.:企業の戦略・SWOT・財務情報
    Buckeye Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Buckeye Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Halozyme Therapeutics Inc (HALO):医療機器:M&Aディール及び事業提携情報
    Summary Halozyme Therapeutics Inc (Halozyme) is a biotechnology company that develops and commercializes novel recombinant human enzymes to provide innovative products for cancer, dermatology, diabetes and drug delivery markets. The company’s marketed product, Hylenex is an agent for drug and fluid …
  • ManpowerGroup, Inc.:企業の戦略・SWOT・財務情報
    ManpowerGroup, Inc. - Strategy, SWOT and Corporate Finance Report Summary ManpowerGroup, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Palram Industries Ltd (PLRM):企業の財務・戦略的SWOT分析
    Palram Industries Ltd (PLRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • 4P-Pharma SAS-製薬・医療分野:企業M&A・提携分析
    Summary 4P-Pharma SAS (4P-Pharma) focuses on the development of novel therapies for the treatment of cancer and inflammatory diseases. The company’s pipeline product portfolio includes new chemical entities, biologics, added value generics and fixed dose combinations. Its pipeline candidates targets …
  • Telecom Italia S.p.A.:企業の戦略・SWOT・財務情報
    Telecom Italia S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Telecom Italia S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • United States Steel Corp (X):企業の財務・戦略的SWOT分析
    United States Steel Corp (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sika AG (SIKA):企業の財務・戦略的SWOT分析
    Sika AG (SIKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • OBB-Infrastruktur AG:企業の戦略的SWOT分析
    OBB-Infrastruktur AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Global Ports Holding PLC (GPH):企業の財務・戦略的SWOT分析
    Global Ports Holding PLC (GPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Tereos:企業の戦略・SWOT・財務分析
    Tereos - Strategy, SWOT and Corporate Finance Report Summary Tereos - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Mobile Telecommunications Company KSCP (ZAIN):企業の財務・戦略的SWOT分析
    Mobile Telecommunications Company KSCP (ZAIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Prakash Constrowell Limited:企業の戦略・SWOT・財務分析
    Prakash Constrowell Limited - Strategy, SWOT and Corporate Finance Report Summary Prakash Constrowell Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Usg Corporation
    Usg Corporation - Strategy, SWOT and Corporate Finance Report Summary Usg Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • INC Research LLC-製薬・医療分野:企業M&A・提携分析
    Summary INC Research LLC (INC Research), a subsidiary of INC Research Holdings Inc is a healthcare services provider that offers contract research services. The organization provides phase I to IV clinical development services. Its services include study start-up, INC pressure test, INC patient elig …
  • LCI Industries:企業の戦略・SWOT・財務分析
    LCI Industries - Strategy, SWOT and Corporate Finance Report Summary LCI Industries - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • North Eastern Electric Power Corporation Ltd-エネルギー分野:企業M&A・提携分析
    Summary North Eastern Electric Power Corporation Limited (NEEPCO) is a government owned electric utility that generates, procures and sells electricity. The company designs, constructs, operates and maintains hydro, thermal and gas projects. NEEPCO generates electricity from hydro, thermal, and sola …
  • Alzheimer’s Drug Discovery Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Alzheimer's Drug Discovery Foundation (ADDF), formerly Institute for the Study of Aging is a drug discovery foundation. The foundation offers funds for drug discovery and development research programs in the field of Alzheimer’s disease, related dementias and cognitive aging. It offers servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆